Jose P. Berros
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
SEOM clinical guidelines to primary prevention of cancer (2018).
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: December 08, 2018
Phase II trial of ifosfamide in combination with the VEGFR inhibitor sorafenib in advanced soft tissue sarcoma: a Spanish group for research on sarcomas (GEIS) study.
Journal: Investigational new drugs
Published: January 17, 2018
Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours.
Journal: Journal of translational medicine
Published: October 13, 2016
BRAF mutation analysis in circulating free tumor DNA of melanoma patients treated with BRAF inhibitors.
Journal: Melanoma research
Published: September 15, 2015
GEINOFOTE: efficacy and safety of fotemustine in patients with high-grade recurrent gliomas and poor performance status.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: May 27, 2015
Prolonged clinical benefit of everolimus therapy in the management of high-grade pancreatic neuroendocrine carcinoma.
Journal: Case reports in oncology
Published: September 11, 2013
Reduced folate carrier (RFC) as a predictive marker for response to pemetrexed in advanced non-small cell lung cancer (NSCLC).
Journal: Investigational new drugs
Published: March 04, 2013
Prognostic factors in patients with advanced renal cell carcinoma.
Journal: Clinical genitourinary cancer
Published: March 13, 2012
Predictive factors for response to treatment in patients with advanced renal cell carcinoma.
Journal: Investigational new drugs
Published: March 12, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026